Related Experiment Videos
ICU acuity: real-time models versus daily models
1CSAIL, Massachusetts Institute of Technology, Cambridge, MA, USA.
Objective:
To explore the feasibility of real-time mortality risk assessment for ICU patients.
Design/Methods:
This study used retrospective analysis of mixed medical/surgical intensive care patients in a university hospital. Logistic regression was applied to 7048 development patients with several hundred candidate variables. Final models were selected by backward elimination on top cross-validated variables and validated on 3018 separate patients.
Results:
The real-time model demonstrated strong discrimination ability (Day 3 AUC=0.878). All models had circumstances where calibration was poor (Hosmer-Lemeshow goodness of fit test p < 0.1). The final models included variables known to be associated with mortality, but also more computationally intensive variables absent in other severity scores.
Conclusion:
Real-time mortality prediction offers similar discrimination ability to daily models. Moreover, the discrimination of our real-time model performed favorably to a customized SAPS II (Day 3 AUC=0.878 vs AUC=0.849, p < 0.05) but generally had worse calibration.
Related Concept Videos
Clearance Models: Noncompartmental Models
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
Clearance Models: Physiological Models
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's proficiency in drug...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacodynamic Models: Overview
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model